Measuring and predicting response to atomoxetine and methylphenidate.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Atomoxetine (Primary) ; Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 27 Feb 2008 New trial centres added.
- 07 Nov 2005 New trial record.